MedMira Elects New Chairman And Director

Prior to joining MedMira, Smith was a member of the Nova Scotia Legislature for 19 years, serving in various roles including Minister of Health. Born and raised in Nova Scotia, Smith received a BSc from the University of British Columbia and his medical degree from Dalhousie University. Smith practiced family medicine in Nova Scotia for 29 years, prior to entering political life. Active in the community, Smith also serves on the board of directors’ of BioNova, the Nova Scotia Biotechnology and Life Sciences Industry Association, the Alzheimer Society of Nova Scotia; the NovaKnowledge advisory council and the advisory board (Atlantic) Ballet Jorgen.

Romano Robusto is a seasoned life sciences executive with over 20 years of experience in the industry, primarily in the diagnostic sector. He has held a broad range of positions including intellectual property, sales, business development, strategic planning and senior management. Robusto most recently served as the interim chief executive officer (CEO) of Radient Technologies and prior to this he worked within the life sciences division of the SGF, the economic development arm of the Quebec Government, responsible for investing development capital into companies that had achieved commercial viability. Mr. Robusto has also held numerous positions within the diagnostic division of Biochem Pharma. He holds degrees in Common and Civil law from McGill University, a BSc in Physical Therapy from McGill University and majored in Biochemistry at Concordia University.

“I was attracted to MedMira because of the innovative diagnostic products being developed by a Nova Scotia company. I saw the value of the Company’s rapid tests as public health tools in fighting global healthcare challenges like HIV and Hepatitis and wanted to be a part of it,” said Smith, chairman of the board. “In my new role I look forward to helping the MedMira team continue to expand into global markets, gain valuable strategic partners, and build shareholder value.”

“On behalf of the Board and the Company I congratulate Dr. Smith on his new role as Chairman and welcome Mr. Robusto,” said Hermes Chan, president and CEO, MedMira “Dr. Smith has been key member of MedMira’s leadership team and we look forward to his continued guidance and perspective as Chairman. Additionally Mr. Robusto’s life science industry experience and insight will be valuable in helping MedMira move forward successfully,” said Hermes Chan, president and CEO, MedMira.